Mini-Oral Abstract Session: Organ Xenotransplant - Clinical Application 2
Tuesday September 30, 2025 from 16:20 to 17:10
Auditorium
Lectures
  • Moderator
    Burcin Ekser, United States
  • Moderator
    Carmen Gonelle-Gispert, Switzerland
  • 110.1 Differential pig and human protein abundance in plasma of patients exposed to pig hepatocytes following bioartificial liver treatments
    Prof. Angeles Baquerizo, United States
  • 110.2 Screening human blood products for xeno-reactive antibodies to ensure compatibility in clinical xenotransplantation
    Dr. Alexander C Schulick, United States
  • 110.3 Monitoring donor-derived cell free DNA in porcine heart xenotransplant recipients
    Dr. Robert Woodward, United States
  • 110.4 Real-time intraoperative quantification of xenograft blood flow into a porcine xenothymokidney in a living human with a left ventricular assist device
    Dr. Jacqueline I. Kim, United States
  • 110.5 Correlation of left ventricular global longitudinal strain with porcine cell-free DNA in the first & second genetically modified porcine to human xeno heart transplant
    Dr. Javier Galindo, United States
  • 110.6 Pig kidney xenograft size after pig-to-human transplantation - GGTA1 KO Thymokidney vs 10 GE Xenokidney
    Dr. Tal Eitan, United States
  • 110.7 How many potential candidates are there for clinical kidney xenotransplantation in Japan?
    Dr. Takayuki Hirose, Japan

© 2025 IXA 2025